Stocks and Investing
Stocks and Investing
Wed, April 7, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, April 6, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Colin Bristow Initiated (ALXO) at Strong Buy and Held Target at $96 on, Apr 6th, 2021
Colin Bristow of UBS, Initiated "ALX Oncology Holdings Inc." (ALXO) at Strong Buy and Held Target at $96 on, Apr 6th, 2021.
Colin has made no other calls on ALXO in the last 4 months.
There are 2 other peers that have a rating on ALXO. Out of the 2 peers that are also analyzing ALXO, 0 agree with Colin's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Colin
- Martin Auster of "Credit Suisse" Maintained at Buy with Increased Target to $98 on, Thursday, February 11th, 2021
- Swayampakula Ramakanth of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $100 on, Wednesday, February 10th, 2021
Contributing Sources